Hims & Hers CLO exercises RSUs, covers taxes

Hims & Hers Health, Inc. Chief Legal Officer Soleil Boughton reported routine equity compensation activity involving restricted stock units (RSUs) on March 13, 2026.

Rhea-AI Filing Summary

Hims & Hers Health, Inc. Chief Legal Officer Soleil Boughton reported routine equity compensation activity involving restricted stock units (RSUs) on March 13, 2026. Multiple RSU awards covering a total of 41,421 units were exercised or converted, each RSU representing one share of Class A common stock.

To cover tax withholding obligations tied to the vesting and settlement of these RSUs, the issuer withheld 168,750 shares of Class A common stock at a price of $24.77 per share, classified as tax-withholding dispositions rather than market sales. Following these transactions, Boughton directly holds 313,643 shares of Class A common stock.

Insider Trade Summary

41,421 shares exercised/converted

Exercise 7 txns

Insider Boughton Soleil

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	10,916	$0.00	$0.00
Exercise	Restricted Stock Unit	12,223	$0.00	$0.00
Exercise	Restricted Stock Unit	12,099	$0.00	$0.00
Exercise	Restricted Stock Unit	6,183	$0.00	$0.00
Exercise Price or Tax Liability	Class A Common Stock	146,577	$24.77	$3.63M
Exercise	Class A Common Stock	41,421	$0.00	$0.00
Exercise Price or Tax Liability	Class A Common Stock	22,173	$24.77	$549K

Holdings After Transaction: Restricted Stock Unit — 219,878 contracts (Direct); Class A Common Stock — 313,643 shares (Direct)

Footnotes (7)

1. F1. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the distribution and settlement of performance restricted stock units that vested on February 23, 2026.
2. F2. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
3. F3. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
4. F4. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.
5. F5. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.
6. F6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.
7. F7. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

FAQ

What insider transactions did HIMS Chief Legal Officer Soleil Boughton report?

Soleil Boughton reported RSU-related transactions that converted 41,421 restricted stock units into Class A common shares. The activity reflects routine equity compensation vesting and settlement, rather than open-market buying or selling of Hims & Hers Health, Inc. stock.

How many HIMS shares were withheld for taxes in Soleil Boughton’s Form 4?

A total of 168,750 Class A common shares were withheld to satisfy tax obligations tied to RSU vesting and settlement, at a price of $24.77 per share. These F-code transactions are tax-withholding dispositions, not discretionary market sales.

How many Hims & Hers (HIMS) shares does Soleil Boughton hold after these transactions?

After the RSU conversions and tax-withholding events, Soleil Boughton directly holds 313,643 shares of Hims & Hers Health Class A common stock. This figure reflects the updated ownership position reported as of the March 13, 2026 transaction date.

What does the M transaction code signify in Soleil Boughton’s HIMS filing?

The M code indicates exercise or conversion of derivative securities, here restricted stock units. Boughton’s filing shows RSUs converting into Class A common stock, turning equity-based compensation into actual shares rather than representing open-market purchases.

Are Soleil Boughton’s HIMS F-code transactions open-market stock sales?

No. The F-code entries represent shares withheld by the issuer to cover tax withholding obligations on vested RSUs. According to the footnotes, these are payments of tax liability using shares, not discretionary sales executed in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 04:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boughton Soleil

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/13/2026		F		146,577(1)	D	$24.77	294,395	D
Class A Common Stock	03/13/2026		M		41,421	A	(2)	335,816	D
Class A Common Stock	03/13/2026		F		22,173(3)	D	$24.77	313,643	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(2)	03/13/2026		M			10,916	(4)	(4)	Class A Common Stock	10,916	$0	0	D
Restricted Stock Unit	(2)	03/13/2026		M			12,223	(5)	(5)	Class A Common Stock	12,223	$0	48,892	D
Restricted Stock Unit	(2)	03/13/2026		M			12,099	(6)	(6)	Class A Common Stock	12,099	$0	96,792	D
Restricted Stock Unit	(2)	03/13/2026		M			6,183	(7)	(7)	Class A Common Stock	6,183	$0	74,194	D

Explanation of Responses:

1. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the distribution and settlement of performance restricted stock units that vested on February 23, 2026.

2. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

3. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

4. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

5. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

7. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.